Legis Daily

A bill to prevent conflicts of interest that stem from the revolving door that raises concerns about the independence of pharmaceutical regulators.

USA115th CongressS-2057| Senate 
| Updated: 11/1/2017
Tammy Baldwin

Tammy Baldwin

Democratic Senator

Wisconsin

Cosponsors (8)
Jeanne Shaheen (Democratic)Margaret Wood Hassan (Democratic)Tom Udall (Democratic)Dianne Feinstein (Democratic)Edward J. Markey (Democratic)Kamala D. Harris (Democratic)Sheldon Whitehouse (Democratic)Joe Manchin (Independent)

Homeland Security and Governmental Affairs Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Pharmaceutical Regulation Conflict of Interest Act This bill amends the Ethics in Government Act of 1978 to prohibit a pharmaceutical regulator from using his or her position as regulator to influence any matter that provides a direct or substantial pecuniary benefit to a former employer or client. The position of pharmaceutical regulator refers to any officer or employee occupying a supervisory position within the Drug Enforcement Administration or the Food and Drug Administration. The bill also prohibits such a pharmaceutical regulator from participating in matters involving an individual or entity with whom the pharmaceutical regulator is negotiating future employment. The bill expands restrictions on lobbying by such pharmaceutical regulators following separation from employment with a pharmaceutical regulatory agency.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 1, 2017
Introduced in Senate
Nov 1, 2017
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
  • November 1, 2017
    Introduced in Senate


  • November 1, 2017
    Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

Government Operations and Politics

A bill to prevent conflicts of interest that stem from the revolving door that raises concerns about the independence of pharmaceutical regulators.

USA115th CongressS-2057| Senate 
| Updated: 11/1/2017
Pharmaceutical Regulation Conflict of Interest Act This bill amends the Ethics in Government Act of 1978 to prohibit a pharmaceutical regulator from using his or her position as regulator to influence any matter that provides a direct or substantial pecuniary benefit to a former employer or client. The position of pharmaceutical regulator refers to any officer or employee occupying a supervisory position within the Drug Enforcement Administration or the Food and Drug Administration. The bill also prohibits such a pharmaceutical regulator from participating in matters involving an individual or entity with whom the pharmaceutical regulator is negotiating future employment. The bill expands restrictions on lobbying by such pharmaceutical regulators following separation from employment with a pharmaceutical regulatory agency.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 1, 2017
Introduced in Senate
Nov 1, 2017
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
  • November 1, 2017
    Introduced in Senate


  • November 1, 2017
    Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Tammy Baldwin

Tammy Baldwin

Democratic Senator

Wisconsin

Cosponsors (8)
Jeanne Shaheen (Democratic)Margaret Wood Hassan (Democratic)Tom Udall (Democratic)Dianne Feinstein (Democratic)Edward J. Markey (Democratic)Kamala D. Harris (Democratic)Sheldon Whitehouse (Democratic)Joe Manchin (Independent)

Homeland Security and Governmental Affairs Committee

Government Operations and Politics

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted